Premium
Epidemiology of Kaposi's Sarcoma
Author(s) -
Marshall James
Publication year - 1965
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1111/ijd.1965.4.1.60
Subject(s) - medicine , epidemiology , transmission (telecommunications) , sarcoma , disease , tribe , race (biology) , white (mutation) , dermatology , demography , pathology , biology , biochemistry , botany , electrical engineering , sociology , anthropology , gene , engineering
Summary and Conclusions Kaposi's sarcoma should be classified in the group of lymphoreticular neoplasms with which it is often associated in Caucasians, if not in African Negroes. It is most prevalent in parts of Europe and Africa. Its clinical and histologic manifestations are everywhere much the same, and there is no evidence that any particular race or tribe is more susceptible than another. Country People are affected more often than city dwellers. In most areas, Kaposi's sarcoma is 10 times commoner in males than in females, but the exceptions to this rule Suggest the intervention of environmental rather than genetic factors. No microbic cause has been identified and experiments in transmission have all failed. The prevalence of the disease in the Negroes of South Africa and its scarcity in their white, coloured and Indian neighbours make it unlikely that an infective agent is involved.